Global Health and Gavi Veteran Anuradha Gupta to Lead Global Immunization at Sabin
03 oct. 2022 10h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Veteran public health leader Anuradha Gupta, who has spearheaded a host of successful global initiatives to improve the health of women and children and...
Veterana de salud global y Gavi, Anuradha Gupta, lidera la inmunización global en Sabin
03 oct. 2022 10h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, Oct. 03, 2022 (GLOBE NEWSWIRE) -- La veterana líder de salud pública Anuradha Gupta, que lideró una serie de iniciativas globales de gran éxito para mejorar la salud de las mujeres y...
Anuradha Gupta, veterana de saúde global e da Gavi lidera a imunização global da Sabin
03 oct. 2022 10h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, Oct. 03, 2022 (GLOBE NEWSWIRE) -- A veterana líder em saúde pública Anuradha Gupta, que liderou uma série de iniciativas globais bem-sucedidas para melhorar a saúde de mulheres e...
Veteran Kesehatan Global dan Gavi, Anuradha Gupta Memimpin Imunisasi Global di Sabin
03 oct. 2022 10h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Veteran pemimpin kesehatan publik, Anuradha Gupta, yang memelopori sejumlah besar prakarsa global yang sukses untuk meningkatkan kesehatan wanita dan...
Anuradha Gupta, spécialiste de la santé mondiale et ancienne cadre chez Gavi, dirigera le programme de vaccination mondiale de Sabin
03 oct. 2022 10h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, 03 oct. 2022 (GLOBE NEWSWIRE) -- Anuradha Gupta, leader chevronnée de la santé publique, qui a dirigé de nombreuses initiatives mondiales couronnées de succès visant à améliorer la santé...
Sabin obtiene $ 21.8 millones adicionales de BARDA para avanzar la vacuna contra el virus de Marburgo
14 sept. 2022 06h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, Sept. 14, 2022 (GLOBE NEWSWIRE) -- El Sabin Vaccine Institute anunció hoy que obtuvo $ 21.8 millones adicionales bajo un contrato existente con la Autoridad de Investigación y Desarrollo...
Sabin recebe US $ 21,8 milhões adicionais da BARDA para o desenvolvimento da Vacina Marburg
14 sept. 2022 06h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, Sept. 14, 2022 (GLOBE NEWSWIRE) -- O Sabin Vaccine Institute anunciou hoje o recebimento de US $ 21,8 milhões adicionais sob um contrato existente com a Biomedical Advanced Research and...
Sabin reçoit 21,8 millions de dollars supplémentaires de la part de la BARDA pour faire progresser le vaccin contre le virus Marburg
14 sept. 2022 06h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, 14 sept. 2022 (GLOBE NEWSWIRE) -- Le Sabin Vaccine Institute a annoncé aujourd'hui avoir reçu 21,8 millions de dollars supplémentaires dans le cadre d'un contrat existant avec la...
Sabin Receives Additional $21.8 Million From BARDA to Advance Marburg Vaccine
14 sept. 2022 06h00 HE
|
The Sabin Vaccine Institute
WASHINGTON, Sept. 14, 2022 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today announced it is receiving an additional $21.8 million under an existing contract with the Biomedical Advanced...
Sabin Vaccine Institute Receives up to $6.3 Million from CEPI for Dose-Optimizing COVID-19 Vaccine Clinical Trial
17 mai 2022 15h48 HE
|
The Sabin Vaccine Institute
Washington, D.C., May 17, 2022 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute was awarded up to $6.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for a clinical trial to...